1978
DOI: 10.1007/978-3-642-66888-3_17
|View full text |Cite
|
Sign up to set email alerts
|

Inflammatory Mediators and Vascular Events

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
6
0

Year Published

1982
1982
2020
2020

Publication Types

Select...
4
2

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(7 citation statements)
references
References 34 publications
1
6
0
Order By: Relevance
“…Anti-inflammatory effects of mepyramine and methysergide have been reported as limited in some inflammatory models, such as thermal injury or carrageenin edema (8), when used in doses proved as effectively antagonize the amines. The doses of these antagonists used here would be enough to antagonize the effect of each amine (9,10), and the pleurisy induced by PMA may be a model where these amines have roles, since PMA has been proven to release histamine and 5 HT in vitro and in vivo to increase vascular permeability.…”
Section: Discussionmentioning
confidence: 99%
“…Anti-inflammatory effects of mepyramine and methysergide have been reported as limited in some inflammatory models, such as thermal injury or carrageenin edema (8), when used in doses proved as effectively antagonize the amines. The doses of these antagonists used here would be enough to antagonize the effect of each amine (9,10), and the pleurisy induced by PMA may be a model where these amines have roles, since PMA has been proven to release histamine and 5 HT in vitro and in vivo to increase vascular permeability.…”
Section: Discussionmentioning
confidence: 99%
“…Various clinical symptoms may exist for most of the ocular surface diseases. For example, mainly caused by the inflammation of the cornea, keratitis typically manifests as a defect of the corneal epithelium and even stromal infiltration, which could cause conjunctival vessel dilation, distortion and congestion, and even lead to abnormal blood vessel growth [4][5][6]. To establish complementary information for the diagnosis and treatment In this study, we developed a multi-modal non-invasive anterior eye imaging platform by combining our customized UHR-OCT and microvascular imaging system based on a functional slit-lamp biomicroscopy to provide both structural and functional information in ophthalmic clinical practice.…”
Section: Introductionmentioning
confidence: 99%
“…With ever-improving techniques in broadband light sources, ultra-high resolution OCT (UHR-OCT) has achieved micron-scale axial resolution [21,22]. UHR-OCT imaging of the ocular surface can now resolve and even measure the thickness of tear film and the major structures, such as the individual corneal layers: the epithelium, the Bowman's membrane, the Stroma, Descemet's membrane and the endothelium [23][24][25][26], which helps clinicians be better in the diagnosis and management of ocular surface pathologies and diseases, including keratitis [23,26], keratoconus [27], ocular surface neoplasia [28], etc.For ocular surface diseases, apart from the physiological structural changes, the microvascular system would also change when the eye is inflamed, as inflammatory mediators would induce a series of vascular changes, including vasodilation, increased permeability and increased blood flow [5,6], which correlates with the severity of the lesion. Techniques like OCT angiography [29,30] have been applied to image the vessels of the anterior segment, but they could only provide morphological information and lack of the function of providing quantitative functional parameters, such as the blood flow velocity.…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…This process can be readily studied by measuring the tissue content of an isotopically labelled protein or a protein-bound dye at different times after injection of the inflammatory agent [1]. A direct relationship between the formation of oedema and an increase of vascular permeability of the tissue surrounding the injury was observed when high doses (500/zg-10 mg) of carrageenan were injected into the hind paw [2,3] but not with doses lower than 100 #g [4].…”
Section: Introductionmentioning
confidence: 99%